Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$448K Sell
826
-800
-49% -$411K 0.01% 280
2026
Q1
$706K Sell
1,626
-200
-11% -$88.1K 0.02% 234
2025
Q4
$600K Sell
1,826
-1,775
-49% -$571K 0.01% 237
2025
Q3
$1.15M Hold
3,601
0.03% 180
2025
Q2
$991K Hold
3,601
0.02% 186
2025
Q1
$664K Sell
3,601
-199
-5% -$46K 0.02% 214
2024
Q4
$748K Sell
3,800
-1,200
-24% -$231K 0.02% 189
2024
Q3
$1.04M Hold
5,000
0.03% 161
2024
Q2
$1.17M Hold
5,000
0.03% 151
2024
Q1
$887K Buy
+5,000
New +$789K 0.03% 169

Other funds holding NVMI

Chicago Capital's NVMI Position: Q2 2026 in Review

Chicago Capital reduced its Nova (NVMI) stake by 49% in Q2 2026, selling an estimated $411K and leaving 826 shares worth $448K. The position accounts for 0.01% of the portfolio, ranked #280.

Chicago Capital first reported a position in NVMI in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.17M in Q2 2024. 345 funds tracked by Wall St. Rank hold NVMI as of Q2 2026.

  • Chicago Capital held 826 shares of Nova worth $448K as of Q2 2026.
  • Chicago Capital sold 800 Nova shares in Q2 2026, an estimated $411K.
  • Nova made up 0.01% of Chicago Capital's portfolio in Q2 2026, its #280 holding.
  • Chicago Capital first reported a position in Nova in Q1 2024 and has held it in 10 quarters since.
  • Chicago Capital's Nova position peaked at $1.17M in Q2 2024.
  • 345 funds tracked by Wall St. Rank held Nova as of Q2 2026.

Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.